Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Women, thrombosis, and cancer
Dominique Farge1, Christine Le Maignan2, Ludovic Doucet2
1Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Unité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04) Centre de Référence des Maladies auto-immunes systémiques Rares d'ile-de-France, Filière FAI2R, F-75010 Paris, France; Département de Médecine, Université McGill, Montreal, Québec, Canada.
Abstract:
Venous thromboembolism (VTE) is a major common complication in cancer patients. Risk-adapted thromboprophylaxis and antithrombotic therapy for patients diagnosed with VTE can reduce the recurrence of VTE events. Thrombotic risk varies according to cancer type, stage, and comorbidities. The current review analyzes most recent data and provides clinical guidance for the management of women with cancer-associated thrombosis.
Related Concept Videos
04:40Venous Thrombosis Assay in a Mouse Model of Cancer
10:26A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:37Ferric Chloride-induced Murine Thrombosis Models
Venous Thrombosis I: Introduction
09:15In Vitro Thrombosis Test for Ventricular Assist Devices
08:45New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

